Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FFWLL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/ml syringes valued at $16,249.95. The contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Stelara is a biologic immunosuppressant medication used to treat various autoimmune conditions, and this delivery order represents the company's continued role as a critical supplier in the federal pharmaceutical supply chain. The award underscores DMS Pharmaceutical Group's established position as a reliable distributor of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The firm's federal procurement success reflects its competitive capability within the woman-owned small business classification and its specialized expertise in serving military and federal healthcare system requirements across diverse pharmaceutical product categories.
Quick answers
Who was awarded contract SPE2DB25FFWLL?
SPE2DB25FFWLL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FFWLL worth?
The government has obligated $16,250 on SPE2DB25FFWLL.
Is contract SPE2DB25FFWLL an order under another contract?
Yes. SPE2DB25FFWLL is a delivery order under SPE2DB24D9315, an indefinite delivery contract.
Was contract SPE2DB25FFWLL competed?
The extent of competition for SPE2DB25FFWLL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award